MannKind Corp Valuation

MNKD Stock  USD 5.21  0.03  0.57%   
At this time, the firm appears to be overvalued. MannKind Corp secures a last-minute Real Value of $4.7 per share. The latest price of the firm is $5.21. Our model forecasts the value of MannKind Corp from analyzing the firm fundamentals such as Shares Outstanding of 275.78 M, return on asset of 0.0912, and Operating Margin of 0.22 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
5.21
Please note that MannKind Corp's price fluctuation is slightly risky at this time. Calculation of the real value of MannKind Corp is based on 3 months time horizon. Increasing MannKind Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the MannKind stock is determined by what a typical buyer is willing to pay for full or partial control of MannKind Corp. Since MannKind Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MannKind Stock. However, MannKind Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  5.21 Real  4.7 Hype  5.21 Naive  5.49
The real value of MannKind Stock, also known as its intrinsic value, is the underlying worth of MannKind Corp Company, which is reflected in its stock price. It is based on MannKind Corp's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of MannKind Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
4.70
Real Value
7.03
Upside
Estimating the potential upside or downside of MannKind Corp helps investors to forecast how MannKind stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MannKind Corp more accurately as focusing exclusively on MannKind Corp's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
4.815.285.76
Details
Hype
Prediction
LowEstimatedHigh
2.885.217.54
Details
Naive
Forecast
LowNext ValueHigh
3.165.497.81
Details

MannKind Corp Total Value Analysis

MannKind Corp is now forecasted to have valuation of 1.43 B with market capitalization of 1.56 B, debt of 47.7 M, and cash on hands of 154.16 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the MannKind Corp fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
1.43 B
1.56 B
47.7 M
154.16 M

MannKind Corp Investor Information

About 61.0% of the company shares are owned by institutional investors. The company last dividend was issued on the 3rd of March 2017. MannKind Corp had 1:5 split on the 3rd of March 2017. Based on the analysis of MannKind Corp's profitability, liquidity, and operating efficiency, MannKind Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.

MannKind Corp Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. MannKind Corp has an asset utilization ratio of 72.49 percent. This indicates that the Company is making $0.72 for each dollar of assets. An increasing asset utilization means that MannKind Corp is more efficient with each dollar of assets it utilizes for everyday operations.

MannKind Corp Ownership Allocation

MannKind Corp maintains a total of 275.78 Million outstanding shares. Over half of MannKind Corp's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

MannKind Corp Profitability Analysis

The company reported the previous year's revenue of 285.5 M. Net Income was 27.59 M with profit before overhead, payroll, taxes, and interest of 192.14 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates MannKind Corp's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in MannKind Corp and how it compares across the competition.

About MannKind Corp Valuation

The stock valuation mechanism determines MannKind Corp's current worth on a weekly basis. Our valuation model uses a comparative analysis of MannKind Corp. We calculate exposure to MannKind Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MannKind Corp's related companies.
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California. Mannkind Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 348 people.

MannKind Corp Growth Indicators

Investing in growth stocks can be very risky. If the company such as MannKind Corp does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding283.8 M
Quarterly Earnings Growth Y O Y5.246
Forward Price Earnings30.4878

Complementary Tools for MannKind Stock analysis

When running MannKind Corp's price analysis, check to measure MannKind Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MannKind Corp is operating at the current time. Most of MannKind Corp's value examination focuses on studying past and present price action to predict the probability of MannKind Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MannKind Corp's price. Additionally, you may evaluate how the addition of MannKind Corp to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stocks Directory
Find actively traded stocks across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume